| Entry |
|
|---|
| Name |
Buformin hydrochloride (JP16);
Dibetos-B (TN)
|
|---|
| Formula |
C6H15N5. HCl
|
|---|
| Exact mass |
193.1094
|
|---|
| Mol weight |
193.6777
|
|---|
| Structure |
     |
|---|
| Activity |
|
|---|
| Remark |
Therapeutic category: ATC code: |
|---|
| Comment |
biguanides
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
396 Antidiabetic agents
3962 Biguanides
D02206 Buformin hydrochloride (JP16)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BA Biguanides
A10BA03 Buformin
D02206 Buformin hydrochloride (JP16)
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine protein kinases: CAMK group
CAMKL family
AMPK [HSA:5562 5563] [KO:K07198]
Buformin [ATC:A10BA03]
D02206 Buformin hydrochloride (JP16)
 |
|---|
| Other DBs |
CAS: 1190-53-0 PubChem: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 12
1 N1b N 26.1791 -14.3037
2 C2c C 24.9663 -15.0034
3 C1b C 27.3919 -15.0034
4 N1b N 23.7535 -14.3037
5 N2a N 24.9663 -16.4028
6 C1b C 28.6047 -14.3037
7 C2c C 22.5407 -15.0034
8 C1b C 29.8175 -15.0034
9 N1a N 21.3280 -14.3037
10 N2a N 22.5407 -16.4028
11 C1a C 31.0303 -14.3037
12 X Cl 18.8300 -15.7500
BOND 10
1 1 2 1
2 1 3 1
3 2 4 1
4 2 5 2
5 3 6 1
6 4 7 1
7 6 8 1
8 7 9 1
9 7 10 2
10 8 11 1
|
|---|
